pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,882 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 9 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: filing×clear all
type
  • phase readout4,876
  • 8k filing2,347
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07028372: Long Term Follow-up of Cardiac Arrest Survivors Exposed to Ultra-rapid Cooling

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Cardiac Arrest (CA), Resuscitated Sudden Cardiac Death, Post Cardiac Arrest Patient Who Was Treated by Hypothermia Protocol

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05359445: IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor

    Sponsor: Immatics Biotechnologies GmbH. Phase: PHASE1. Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07585695: Coronary Artery Disease Screening in Patients With Chronic Kidney Disease

    Sponsor: University Hospital, Grenoble. Phase: . Conditions: Chronic Kidney Disease (CKD), Coronary Artery Disease (CAD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05408845: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

    Sponsor: NRG Oncology. Phase: PHASE2. Conditions: Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8, Stage IV Major Salivary Gland Cancer AJCC v8, Unresectable Salivary Gland Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00515372: Depression Treatment and Screening in Ovarian Cancer Patients

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06814795: Medically Tailored Meals for Kids

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Pediatric Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07542431: Impact of Dog Adoption and Training in Veterans With Post-traumatic Stress Symptoms and/or Other Mental Health Conditions

    Sponsor: Florida Atlantic University. Phase: NA. Conditions: Posttraumatic Stress Symptoms, Mental Health Conditions

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05763602: PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

    Sponsor: Loreen Herwaldt. Phase: PHASE4. Conditions: Surgical Site Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07550439: Effect of World Health Organization Labour Care Guide On Reducing Cesarean Section Rates

    Sponsor: Pak Emirates Military Hospital. Phase: NA. Conditions: Labour

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07602465: The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury

    Sponsor: Zhongda Hospital. Phase: . Conditions: Acute Kidney Injury (AKI)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03773965: A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Juvenile Idiopathic Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07413965: TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

    Sponsor: Cedars-Sinai Medical Center. Phase: NA. Conditions: Bicuspid Aortic Valve Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06923267: Ultrasound Evaluation of Cardiac Function During Spontaneous Breathing Trials

    Sponsor: Centre Hospitalier Régional d'Orléans. Phase: NA. Conditions: Weaning Invasive Mechanical Ventilation, Weaning-induced Pulmonary Edema, Weaning Failure of Mechanical Ventilation, Spontaneous Breathing Test, Intensive Care Units (ICUs)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07545967: Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy

    Sponsor: West China Hospital. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07196007: Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes

    Sponsor: Mary Lacy. Phase: NA. Conditions: Diabetes, Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00862992: Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE2. Conditions: Schizophrenia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07612592: The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome

    Sponsor: Children's Hospital of Chongqing Medical University. Phase: . Conditions: Primary Nephrotic Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04972136: rTMS for Depression in Young Adults With Autism

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Autism Spectrum Disorder, Major Depressive Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01805336: Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality

    Sponsor: University Hospital, Caen. Phase: NA. Conditions: Relapsing-Remitting Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07097311: Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

    Sponsor: Jerry Vockley, MD, PhD. Phase: PHASE2. Conditions: Medium-chain Acyl-CoA Dehydrogenase Deficiency

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04519671: Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

    Sponsor: Anthony Lembo. Phase: PHASE1. Conditions: Perianal Crohn Disease, Perianal Fistula, Crohn Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07436364: Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy

    Sponsor: Thomas Jefferson University. Phase: EARLY_PHASE1. Conditions: Soft Tissue Sarcoma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04548609: Transcranial Direct Current Stimulation (tDCS) in Pediatric Obsessive Compulsive Disorder (OCD)

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04328298: French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)

    Sponsor: The Lymphoma Academic Research Organisation. Phase: . Conditions: Hematopathology Eligible or CAR-t Cell Treatment

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05565599: An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

    Sponsor: Biosense Webster, Inc.. Phase: NA. Conditions: Non-valvular Atrial Fibrillation

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07404098: Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized Plasmatic Matrix in Posterior Mandibular Socket Preservation

    Sponsor: Cairo University. Phase: NA. Conditions: Alveolar Bone Resorption, Socket Preservation, Wound Healing, Nano-hydroxyapatite

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07216963: The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study

    Sponsor: Duke University. Phase: NA. Conditions: Opioid Use Disorder, Overdose, Drug, Overdose, Substance Use (Drugs, Alcohol)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07288463: Hearing Loss and Brain Health Study

    Sponsor: University of Southern California. Phase: NA. Conditions: Hearing Loss, Adult-Onset, Dementia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07139314: Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

    Sponsor: Capital Medical University. Phase: NA. Conditions: Ischemic Stroke, Atrial Fibrillation

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06993116: A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors

    Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE1. Conditions: Advanced Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03126916: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

    Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04744116: Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

    Sponsor: M.D. Anderson Cancer Center. Phase: EARLY_PHASE1. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07410052: Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination

    Sponsor: Center for Health Sciences, Serbia. Phase: NA. Conditions: Cognitive Deficits, Mild

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07365852: Accuracy Assessment of Chin Graft for Ridge Augmentation Using Tooth-supported Guide Versus Free Hand Technique

    Sponsor: Cairo University. Phase: NA. Conditions: Alveolar Bone Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03321552: PROMISE International

    Sponsor: LimFlow SA. Phase: NA. Conditions: Critical Limb Ischemia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05741242: A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

    Sponsor: Jaime Leandro Foundation for Therapeutic Cancer Vaccines. Phase: PHASE1. Conditions: Cancer, Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06940986: The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System

    Sponsor: Brooke Army Medical Center. Phase: NA. Conditions: Chronic Pain, Musculoskeletal Pain, Musculoskeletal Pain Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07538973: A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function

    Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07563673: Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)

    Sponsor: Beijing Chao Yang Hospital. Phase: PHASE4. Conditions: Cerebral Infarction, Thrombolysis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07602283: Music for Pain and Dementia

    Sponsor: Yale University. Phase: NA. Conditions: Alzheimer Disease, Dementia, Mild Cognitive Impairment, Peer-bonded Caregiver, Caregiver

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04707183: Comparison of Continuous Intravenous Lidocaine Infusion Versus ESP Block for Rib Fracture Analgesia

    Sponsor: Stanford University. Phase: PHASE2. Conditions: Rib Fractures

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04455841: INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

    Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Anemia, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03198494: Acoustic Stimulation for Seizure Suppression

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Epilepsy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05925166: Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout

    Sponsor: Lihua Duan. Phase: NA. Conditions: Acute Gout

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07592156: Immersive Virtual Reality Versus Conventional Physiotherapy for Shoulder Tendinopathy

    Sponsor: Universidad de Burgos. Phase: NA. Conditions: Shoulder Tendinopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06310551: First Time in Human Study of Long Acting VH4524184 Formulations

    Sponsor: ViiV Healthcare. Phase: PHASE1. Conditions: HIV Infections

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03624751: Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

    Sponsor: Taichung Veterans General Hospital. Phase: . Conditions: Thyroid Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05962151: Refractory Chronic Cough Improvement Via NAL ER (RIVER)

    Sponsor: Trevi Therapeutics. Phase: PHASE2. Conditions: Refractory Chronic Cough

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05209737: Trendelenburg as a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients

    Sponsor: Negovsky Reanimatology Research Institute. Phase: NA. Conditions: Hypotension, Shock

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06642337: Nutritional Educational Program On Therapy in Iron Deficiency Anemia

    Sponsor: Hawler Medical University. Phase: NA. Conditions: Iron Deficiency Anemia (IDA), Nutrition Disorders, Growth Retardation

    full page →ctgov ↗
    ← prev
    page 40 of 98
    next →